| 11230547 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta |
Meredeth A. McGowan, Jason Katz, Hua Zhou, David J. Witter, Chaomin Li +5 more |
2022-01-25 |
$195,577,000 |
| 10544147 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta |
Abdelghani Achab, Francesc Xavier Fradera Llinas, Jason Katz, Joey L. Methot, Hua Zhou +5 more |
2020-01-28 |
$79,189,000 |
| 9938281 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta |
Abdelghani Achab, Michael D. Altman, Yongqi Deng, Solomon D. Kattar, Jason Katz +16 more |
2018-04-10 |
$62,414,000 |
| 9730940 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta |
Abdelghani Achab, Michael D. Altman, Yongqi Deng, Timothy J. Guzi, Solomon D. Kattar +12 more |
2017-08-15 |
$57,816,000 |
| 9682978 |
2,6,7 substituted purines as HDM2 inhibitors |
Francesc Xavier Fradera Llinas, Michelle R. Machacek, Michelle Martinez, Michael H. Reutershan, Manami Shizuka +5 more |
2017-06-20 |
$284,541,000 |
| 9586931 |
Triazolyl derivatives as Syk inhibitors |
Michelle R. Machacek, Eric T. Romeo, Solomon D. Kattar, Michael D. Altman, Alan B. Northrup +17 more |
2017-03-07 |
$72,118,000 |
| 9540377 |
2,6,7,8 substituted purines as HDM2 inhibitors |
Carolyn Michele Cammarano, Christopher J. Dinsmore, Ronald J. Doll, Francesc Xavier Fradera Llinas, Chaomin Li +16 more |
2017-01-10 |
$109,765,000 |
| 9487504 |
Imidazolyl analogs as syk inhibitors |
Jongwon Lim, Michael H. Reutershan, John Michael Ellis, Kaleen Konrad Childers, Anthony Donofrio +11 more |
2016-11-08 |
$82,214,000 |
| 9416111 |
Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors |
Andrew M. Haidle, Michael D. Altman, Solomon D. Kattar, John Michael Ellis, Christian Fischer +2 more |
2016-08-16 |
$77,022,000 |
| 9376418 |
Substituted pyridine spleen tyrosine kinase (SYK) inhibitors |
Andrew M. Haidle, Sandra Lee Knowles, Solomon D. Kattar, Denis Deschenes, Jason Burch +12 more |
2016-06-28 |
$48,646,000 |
| 9353066 |
Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors |
Andrew M. Haidle, Jason Burch, Daniel Guay, Jacques Yves Gauthier, Joel Robichaud +5 more |
2016-05-31 |
$68,752,000 |
| 9328099 |
Cyanomethylpyrazole carboxamides as janus kinase inhibitors |
Jason D. Brubaker, Matthew L. Childers, Joshua Close, Jason Katz, Joon Jung +8 more |
2016-05-03 |
$59,926,000 |
| 9242984 |
Pyrazolyl derivatives as Syk inhibitors |
Michelle R. Machacek, Michael D. Altman, Eric T. Romeo, Dilrukshi Vitharana, Brandon D. Cash +21 more |
2016-01-26 |
$42,047,000 |
| 8993756 |
Pyrrolopyrimidines as janus kinase inhibitors |
Sean P. Ahearn, Christopher J. Dinsmore, Joon Jung, Qinglin Pu, Alexey Rivkin +4 more |
2015-03-31 |
$66,424,000 |
| 8962611 |
Substituted imidazopyridines as HDM2 inhibitors |
Francesc Xavier Fradera Llinas, Michelle R. Machacek, Michelle Martinez, Michael H. Reutershan, Manami Shizuka +7 more |
2015-02-24 |
$132,352,000 |
| 8846657 |
Substituted imidazopyridines as HDM2 inhibitors |
Francesc Xavier Fradera Llinas, Michelle R. Machacek, Michelle Martinez, Michael H. Reutershan, Manami Shizuka +7 more |
2014-09-30 |
$59,576,000 |
| 8575150 |
Triazole derivatives for treatment of Alzheimer's disease |
Christian Fischer, Joey L. Methot, Hua Zhou, Adam J. Schell, Benito Munoz +8 more |
2013-11-05 |
$76,609,000 |
| 8367706 |
Inhibitors of janus kinases |
Michael D. Altman, Jonathan B. Grimm, Andrew M. Haidle, Kaleen Konrad, Jongwon Lim +12 more |
2013-02-05 |
$75,079,000 |
